Clinical Trial Update: Systemic Anti-Cancer Therapy Dose Modifications for Individuals With Duffy Null Phenotype [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating dose modifications of systemic anti-cancer therapy in individuals with the Duffy null phenotype. The study enrolls patients with mult…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma
• Triple-negative Breast Cancer

Snippet

Sponsor: Andrew Hantel, MD | Conditions: Multiple Myeloma, Triple Negative Breast Cancer | Phase 1 | Status: NOT_YET_RECRUITING